Switzerland
Commercial and general management leader in specialty pharmaceuticals with experience running multi-market businesses across Asia Pacific, Europe, and emerging markets. Most recently served as Head of Asia at CSL Vifor, leading a ~$150M regional P&L across 14 affiliate and partner markets. My background spans regional general management, international commercial strategy and launch execution. I have led multi-country commercial organizations, driven launches and relaunches of specialty medicines, and partnered closely with distributors and affiliates across Asia Pacific, Europe, LATAM, and the Middle East. I bring a pragmatic global-to-local perspective, having worked across local affiliates, regional leadership roles, and global HQ functions. My experience includes portfolio strategy, market access, launch excellence, and building high-performing teams in both direct and partner-led markets. I’m particularly interested in leadership opportunities involving regional general management, international commercial strategy, and scaling specialty pharmaceutical businesses across multiple markets. Key experience includes: Commercial strategy | General management | International markets | Product launches | Market access & pricing | Distributor and partner-led markets | Portfolio strategy | Organizational transformation
Full regional P&L ownership (~$150M) across 15 Asia-Pacific affiliate and partner markets spanning Southeast Asia, East Asia, and Oceania, with accountability for growth, profitability and operational performance. • Delivered +38% YoY revenue growth while improving OPEX efficiency (-16% vs budget) and increasing operating profit. • Led and developed a cross-functional regional organization, strengthening commercial capabilities across affiliates and distributor markets. • Set regional commercial strategy and execution priorities across marketing, sales, launch readiness, and market access. • Board Director, Vifor Fresenius Kabi China (JV), contributing to governance, strategic direction, and market expansion.
• Led commercial strategy and performance for a ~$450M iron portfolio across LATAM, MENA, CEESA (Europe), and Asia, spanning 20+ affiliate and distributor markets. • Delivered +18% YoY growth across complex partner-led markets by strengthening execution, governance, and distributor alignment. • Led multiple international launches and relaunches, including delivering 400% of first-year forecast for a flagship nephrology launch and establishing the Canadian affiliate. • Chaired a cross-regional Commercial, Market Access, and Medical governance forum to accelerate launch execution and performance tracking.
• Global HQ asset lead for specialty and rare-disease products, co-owning global strategy, positioning, and lifecycle planning across EU5 and international markets. • Developed launch frameworks, value propositions, and strategic messaging adopted by global affiliates to support market entry and growth. • Led global brand governance forums and in-market workshops to align regional and country leadership on launch execution and performance priorities.